Home Stock

Stock Research: JMDC

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

JMDC

TYO:4483 JP3386690006
28
  • Value
    20
  • Growth
    77
  • Safety
    Safety
    31
  • Combined
    24
  • Sentiment
    47
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

JMDC Inc. is a Japan-based company focused on health big data, telemedicine, and dispensing pharmacy support. It operates in Health Big Data (receipt data analysis, health promotion solutions, medical and drug database management), Telemedicine (remote image diagnosis services), and Dispensing Pharmacy Support (business systems, electronic medication records, pharmacy operations). The company primarily operates in Japan. In the last fiscal year, the company had 2187 employees, a market cap of $1654 million, profits of $159 million, and revenue of $278 million.

more

ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock JMDC are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for JMDC. The consolidated Growth Rank has a good rank of 77, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 77% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 20 means that the share price of JMDC is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 80% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 31, which means that the company has a riskier financing structure than 69% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 47, indicating professional investors are more pessimistic about the stock than for 53% of alternative investment opportunities. ...read more

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank Analyst Opinions
Country Japan
Industry Health Care Technology
Size Medium
Website jmdc.co.jp
Index
JMDC stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Oct-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 55 29 19
Growth
77 65 85 61
Safety
Safety
31 33 39 21
Sentiment
47 53 35 87
360° View
360° View
28 46 40 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
97 77 66 92
Opinions Change
50 18 21 50
Pro Holdings
n/a 43 16 53
Market Pulse
21 58 74 75
Sentiment
47 53 35 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 55 29 19
Growth
77 65 85 61
Safety Safety
31 33 39 21
Combined
24 41 44 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
19 41 15 20
Price vs. Earnings (P/E)
30 53 35 19
Price vs. Book (P/B)
34 62 38 27
Dividend Yield
39 56 40 44
Value
20 55 29 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
86 74 79 69
Profit Growth
39 50 75 64
Capital Growth
86 77 100 22
Stock Returns
29 33 35 71
Growth
77 65 85 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
26 17 34 9
Refinancing
44 49 40 32
Liquidity
53 70 59 53
Safety Safety
31 33 39 21

Similar Stocks

Discover high‑ranked alternatives to JMDC and broaden your portfolio horizons.

MediPal Holdings

TYO:7459
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Cosmo Energy Holdings

TYO:5021
Country: Japan
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Japan Lifeline

TYO:7575
Country: Japan
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

KOSÉ

TYO:4922
Country: Japan
Industry: Personal Products
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews